390 likes | 539 Views
CRM-IPHA-UNFPA-SPZ-Delhi-080308. 2. 52nd NATIONAL CONFERENCE OF IPHA . PLENARY SESSION Methodological Issues Involved in the Detection of Chronic Reproductive Morbidities including Strategic Interventions for Prevention, Early Detection, and ManagementSanjay P. Zodpey, MD, PhD. CRM-IPHA-UNFPA-
E N D
1. CRM-IPHA-UNFPA-SPZ-Delhi-080308 1 52nd NATIONAL CONFERENCE OF IPHA PLENARY SESSION
CHRONIC REPRODUCTIVE MORBIDITY
Dr. Sanjay P. Zodpey, MD, PhD
Director,
Public Health Education,
Public Health Foundation of India (PHFI),
New Delhi
2. CRM-IPHA-UNFPA-SPZ-Delhi-080308 2 52nd NATIONAL CONFERENCE OF IPHA PLENARY SESSION
Methodological Issues Involved in the Detection of Chronic Reproductive Morbidities including Strategic Interventions for Prevention,
Early Detection, and Management
Sanjay P. Zodpey, MD, PhD
3. CRM-IPHA-UNFPA-SPZ-Delhi-080308 3 SCOPE OF PRESENTATION Emphasis on CRM specific issues
Emphasis – not on individual diseases
Basis – Review of studies
Scarcity of information - CRM
4. CRM-IPHA-UNFPA-SPZ-Delhi-080308 4 Study Design
Setting
Duration of Study
Sample Size / Power Analysis / Sampling
Selection of Subjects
Study Variables
Data Collection Techniques
Study Instruments
5. CRM-IPHA-UNFPA-SPZ-Delhi-080308 5 Measurement Devices & Technical Procedures
Randomization / Matching
Interventions
Follow up Procedures
Bias
Informed Consent
Ethical and IRB Clearance
Statistical Methods
6. CRM-IPHA-UNFPA-SPZ-Delhi-080308 6 CHRONIC REPRODUCTIVE MORBIDITY (CRM) - ISSUES The primary need in any research is adequate, accurate and reliable information to base assumptions
The methodological issues are complicated by:
Varying time-spans of diseases
A prevalent culture of silence and
Poor diagnostic methods
7. CRM-IPHA-UNFPA-SPZ-Delhi-080308 7 Methodological issues in research:
Early detection (diagnostic and screening)
Detection (prevalence and incidence studies)
Risk factor identification (analytic studies)
Community perceptions (qualitative tools)
Designing strategic interventions for prevention (clinical and community trials, operational research) and
Case management (clinical trials)
8. CRM-IPHA-UNFPA-SPZ-Delhi-080308 8 MEASURING REPRODUCTIVE HEALTH Current focus – mortality
Even Global Burden of Disease Study is mortality-centric and fails to capture the spectrum of reproductive morbidity and associated disability
9. CRM-IPHA-UNFPA-SPZ-Delhi-080308 9 MEASURING REPRODUCTIVE HEALTH Measurement Trap:
Narrow conceptualization of women’s reproductive health
Poor existing data sources
Focus solely on measures of disease, particularly mortality
Lack of community based data
10. CRM-IPHA-UNFPA-SPZ-Delhi-080308 10 KEY ISSUES IN METHODOLOGY - CRM Recruitment strategies
Self reported reproductive morbidities (SRRM)
Biologic measurements
11. CRM-IPHA-UNFPA-SPZ-Delhi-080308 11 RECRUITMENT STRATEGIES Many studies are underpowered because of inadequate enrollment
Care seeking for reproductive health among women is inadequate and inequitable in India because of
A lack of access to resources
Limited decision making power
Restricted autonomy and
Reduced freedom of movement
12. 12 RECRUITMENT STRATEGIES Little research has been done to compare different recruitments models
Participants were recruited from an outpatient clinic and community
Community supported enrolment process (community preparation, reproductive health education and screening of potential participants) yielded higher recruitment and retention
13. CRM-IPHA-UNFPA-SPZ-Delhi-080308 13 RECRUITMENT STRATEGIES Clinic and hospital based research on reproductive tract: Advantages
Protecting privacy and confidentiality
Obtaining appropriate examination and interviewing space is easier
Collection and transportation of laboratory specimens presents fewer difficulties
14. CRM-IPHA-UNFPA-SPZ-Delhi-080308 14 RECRUITMENT STRATEGIES Clinic and hospital based research on reproductive tract: Limitations
Women avoid treatment because of lack of knowledge
Shame and embarrassment
Stigma and inhibitions
15. CRM-IPHA-UNFPA-SPZ-Delhi-080308 15 SELF REPORTED REPRODUCTIVE MORBIDITIES (SRRM)
Community based prevalence of reproductive morbidity using household interview surveys
Advantages over other approaches that rely on hospital statistics / medical examinations
16. CRM-IPHA-UNFPA-SPZ-Delhi-080308 16 SRRM - ADVANTAGES A greater depth of population is covered (given higher response rates and lower cost)
Interpretation of findings is simplified
Generalization to the source population is achieved
Potential to estimate the prevalence of conditions that may only be self-reported
17. Identify conditions that escape the attention of health services
Investigate individual, social and environmental determinants
Assess the consequences or impact of illness CRM-IPHA-UNFPA-SPZ-Delhi-080308 17
18. CRM-IPHA-UNFPA-SPZ-Delhi-080308 18 SRRM - LIMITATIONS For mild conditions:
Urban Estimates > Rural Estimates
For severe conditions:
Urban Estimates = Rural Estimates
With higher educational and income level:
Increase in reporting of morbidities
19. CRM-IPHA-UNFPA-SPZ-Delhi-080308 19 SRRM – QUALITATIVE METHODS Addition of qualitative investigations help to improve the conceptual and methodological limitations of household interview survey as well as the interpretation of results
Such investigations document how women describe in their own words their experience with illness, signs and symptoms, and probable cause or consequences of illness
20. SRRM – QUALITATIVE METHODS
Self-report of a morbidity that requires clinical or diagnostic tests to confirm diagnosis may provide an estimate of people’s knowledge of disease rather than estimate its true prevalence
21. CRM-IPHA-UNFPA-SPZ-Delhi-080308 21 SRRM – QUALITATIVE METHODS The commonly utilized ethnographic and anthropological methods are:
Informal, open-ended interviews
In-depth interviews
Illness narratives
Sorting and ranking of key concepts
FGDs
22. CRM-IPHA-UNFPA-SPZ-Delhi-080308 22 CHALLENGES IN SRRM Many conditions are asymptomatic
Are stigmatized and thus likely to be misreported
Prevalent culture of silence with reluctance to reveal private problems to strangers
Women’s inferior status within the family
Conditions are frequently prevalent and their symptoms are considered the norm and thus are not reported as morbidity
23. CRM-IPHA-UNFPA-SPZ-Delhi-080308 23 Prevalence estimates based on SRRM are generally more specific than sensitive
Different approaches to asking questions influence estimates of validity
Different interviewers and interview conditions influence the reliability of prevalence estimates
24. CRM-IPHA-UNFPA-SPZ-Delhi-080308 24 SRRM – LIMITATIONS OF EXISTING LITERATURE Some studies use a combination of self-reported & observed morbidity but fail to compare findings in terms of sn & sp
Other studies are not specifically designed to compare self-reported and observed morbidity
Suffer from low participation or case identification rates
Collect observed morbidity data limited to symptomatic women or to women who self-report
25. CRM-IPHA-UNFPA-SPZ-Delhi-080308 25 SRRM – ESTIMATES DEPENDANT ON PREVALENCE When a specific morbidity’s prevalence is low (e.g. = 5%), a survey tool with a specificity and sensitivity of > 50% will always overestimate the prevalence of disease, unless the specificity approaches 100%
The sn and sp of a set of questions depend upon the prevalence of reported symptoms in the population under study
26. CRM-IPHA-UNFPA-SPZ-Delhi-080308 26 Sensitivity is biased upwards and specificity downwards if the study population has a higher proportion of symptomatic women than the general population
The opposite is true if the study population has a lower proportion of symptomatic women
27. CRM-IPHA-UNFPA-SPZ-Delhi-080308 27 EARLY FINDINGS FROM INDUSTRIALIZED COUNTRIES Methodological Issues:
SRRM is only slightly to moderately associated with observed morbidity for a range of conditions
The high degree of false negative self-reports prevents valid estimation of the prevalence
Psychological and behavioral factors, along with health and medical knowledge, influence SRRM
28. CRM-IPHA-UNFPA-SPZ-Delhi-080308 28 RECENT FINDINGS FROM INDUSTRIALIZED COUNTRIES Methodological Issues:
Document wider range of agreement between self-reported and observed morbidity in aggregate
For larger studies evaluating a range of chronic illnesses, under-reporting was more problematic than over-reporting
29. CRM-IPHA-UNFPA-SPZ-Delhi-080308 29 RECENT FINDINGS FROM DEVELOPING COUNTRIES Methodological Issues:
Questions the validity, reliability and comparability of the estimates obtained
Studies that rely on self reported morbidity to estimate prevalence do not include validation components
Prevalence estimates appear to be sensitive to minor differences in methodology
30. CRM-IPHA-UNFPA-SPZ-Delhi-080308 30 Methodological Issues:
Non-standardized interviewing techniques
The use of open-ended or closed questions
The degree of probing
The inclusion of proxy respondents
Variations in the length of recall periods
Limited concordance between an episode of illness and the recall period
31. CRM-IPHA-UNFPA-SPZ-Delhi-080308 31 Methodological Issues:
Failure to encourage local populations to participate in the design of questionnaires and sampling approaches
The neglect of traditional providers and alternative care sources
SRRM and observed morbidity measure different phenomena
32. CRM-IPHA-UNFPA-SPZ-Delhi-080308 32 MEASURING REPRODUCTIVE HEALTH – USE OF ALGORITHMS Methodological Issues:
Interview-based diagnosis of morbidity through use of algorithms that combine different categories of self-reported morbidity have significant advantages
Brief algorithms may be as sensitive and specific as longer interview schedules
A range of algorithms for the diagnosis of interest may be used in different situations
33. 33
34. 34
35. CRM-IPHA-UNFPA-SPZ-Delhi-080308 35 WHY DO WE NEED BIOLOGIC MEASUREMENT? Traditionally, epidemiologists have used interview information, which is subject to recall bias
Many conditions, such as asymptomatic STIs may not be recognized by respondents
36. CRM-IPHA-UNFPA-SPZ-Delhi-080308 36 BIOLOGIC MEASUREMENTS - LIMTATIONS Biologic measurement requires clinical examinations or specialized investigations, which are invasive and often costly
Transporting viable organisms for microbiologic culture is difficult
Generalization of such findings is limited by the self selection of clinic populations
37. CRM-IPHA-UNFPA-SPZ-Delhi-080308 37 METHODOLOGICAL CHALLENGES Ensuring a close interaction with the community
Provision of appropriate medical treatment
Complementing quantitative and qualitative methods
Handling under-reporting of morbidities
38. METHODOLOGICAL CHALLENGES
Devising methods to improve reporting validity
Sample loss and self selection in reproductive diseases
Establishing standard definitions for diseases
39. CRM-IPHA-UNFPA-SPZ-Delhi-080308 39